To contact us Click HERE
Here are some excerpts from the NYTimes (with my comments below):
Both the Auvi-Q and EpiPen contain the drug epinephrine, which can halt a severe allergic reaction, known as anaphylaxis.
Auvi-Q is the culmination of a single-minded quest that began 15 years ago and ended in a $230 million licensing deal with the French pharmaceutical giant Sanofi.
It boldly challenges the superiority of the EpiPen at a time when food allergies among children and teenagers are on the rise.
This 2-minute video shows the Sanofi's new voice guided Auvi-Q epinephrine injector in action:
Video instructions on use of the EpiPen (epinephrine/adrenaline) autoinjector for anaphylaxis from the Australasian Society of Clinical Immunology and Allergy (ASCIA):
Auvi-Q will appeal to a gadget-hungry generation with its compact, rectangular design and automated voice instructions that guide a user through the injection process. One food allergy patient called the new Auvi-Q epinephrine injector "Siri for EpiPen" (Siri is Apple's voice-enabled personal assistant). Auvi-Q comes with a downloadable app for iPhone/iPod/iPad, and soon, for Android.
The Auvi-Q website features many helpful materials including a list of questions for your doctor (PDF). The Allergy ID Card and Eating Out Card are very helpful but the Action Plan is poorly designed and somewhat confusing (PDFs). The generic action plan available from the FAAN website is preferable (PDF). I use a modified version of the action plan (embedded below) and will add Auvi-Q to the list of the injectors in the next few days:
Auvi-Q has created a stir among allergy sufferers, including bloggers and others who have praised its compact design and “cool” factor. It is smaller than a deck of cards.
You can quickly realize the best feature of the device. Just give the Auvi-Q to anyone and ask them to figure how to use it by themselves. Once they pull the cover, the voice navigation kicks in and they will be done in 10 seconds. It is nearly impossible to achieve this quick understanding with the previous epinephrine injectors.
The EpiPen CEO is not so impressed by Auvi-Q: "“EpiPen has been tried and true for 25 years,” Ms. Bresch said, and argued that her product’s distinctive shape worked to its advantage. “It’s not easily confused with a BlackBerry or your phone in your purse or your backpack.”
However, “People might find it easier to have that in a pocket compared to carrying a giant Magic Marker,” said one prominent allergist, Dr. Sicherer.
Sanofi has set a price for the Auvi-Q that is comparable to the EpiPen, charging $240 for two auto-injectors and a training device.
Still, the Auvi-Q faces long odds: several other companies have tried and failed to challenge the dominance of the EpiPen. Last year, the manufacturer of the only competing products on the market, the Adrenaclick and Twinject, announced it would stop making them.
References:
Auvi-Q Challenges EpiPen With a New Shape and Size - NYTimes.
Comments from Twitter:
EpiPen or Auvi-Q (i.e. Allerject)? Blog post by @Allergy shows pros/cons of both with instructional videos
Hiç yorum yok:
Yorum Gönder